Search

Your search keyword '"E. Tanaka"' showing total 2,712 results

Search Constraints

Start Over You searched for: Author "E. Tanaka" Remove constraint Author: "E. Tanaka"
2,712 results on '"E. Tanaka"'

Search Results

53. Escaping the Ashby limit for mechanical damping/stiffness trade-off using a constrained high internal friction interfacial layer

54. Structural changes and microstructures of Ba1-x Sr x Al2O4 for 0 < x < 0.4

55. Measurements of the branching fraction and spectral function in the decay τ−→π−π+π−π0ντ

57. Structural Phase Transition and Microstructures in Stuffed Tridymite-Type Compounds; Ba(Al, Fe)2O4

58. Bursaphelenchus niphades n. sp. (Tylenchina: Aphelenchoididae) amensally associated with Niphades variegatus (Roelofs) (Coleoptera: Curculionidae)

59. 508P Prognostic factors of soft tissue sarcoma (STS) treated with pazopanib from Nishinomiya Sarcoma Cohort Study (NSCS)

61. PIH67 THE CHANGES OF COST FOR PREECLAMPSIA PREGNANCY AFTER THE ANGIOGENIC FACTORS (SFLT-1 AND PLGF) TESTS. PRELIMINARY DATA OF AN ECONOMIC MODEL BASED ON LOCAL RWD

62. PCN38 IMPACT OF CERVICAL CANCER SCREENING TIME ON SURGICAL OUTCOMES

63. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries

64. Poster Sessions

66. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

67. PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

69. Work Accident Costs. Security, Healthcare and Human Resources Departments Links

70. Defining and finding the rare donor

71. Clinical benefits of later line trabectedin and eribulin treatment for soft tissue sarcoma (STS) after pazopanib treatment from the Nishinomiya Sarcoma Cohort Study (NSCS)

72. Patient Satisfaction, Adherence , Compliance , Persistence in Healthcare . Preliminary Real-World Evidence (RWE) in a Private Health Insurance in Latin America Country

73. A novel constitutive model of skeletal muscle taking into account anisotropic damage

74. Amplification of chromosomal segment 4q12 in non-small cell lung cancer

76. Contents Vol. 42, 2009

77. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

79. Fulminant liver failure secondary to haemorrhagic dengue in an international traveller

80. Development of the RF-IGISOL at CYRIC

82. Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals

83. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization

84. Deletion of theMycobacterium tuberculosisResuscitation-Promoting Factor Rv1009 Gene Results in Delayed Reactivation from Chronic Tuberculosis

85. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension

86. A Case of Penetration of the Transverse Colon by a Fish Bone Recovered with Conservative Therapy

87. Measurement of the g-Factor of the 27− High-Spin Isomer State of 152Dy

88. Rebound phenomenon to systemic corticosteroid in atopic dermatitis

89. Pharmacogenetics of disease-modifying anti-rheumatic drugs

90. Human Biomechanics and Injury Prevention

91. Gene expression in the tuberculous granuloma: analysis by laser capture microdissection and real-time PCR

92. Artificial induction of third-stage dispersal juveniles of Bursaphelenchus xylophilus using newly established inbred lines

96. Nodular Regenerative Hyperplasia

97. The Inducible Nitric Oxide Synthase Locus Confers Protection against Aerogenic Challenge of Both Clinical and Laboratory Strains ofMycobacterium tuberculosisin Mice

98. Vortex-induced oscillation of a bridge in slowly fluctuating wind

99. Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents

100. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride intoxicated rat

Catalog

Books, media, physical & digital resources